Alliancebernstein L.P. Purchases 20,300 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Alliancebernstein L.P. raised its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 28.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 91,445 shares of the company's stock after buying an additional 20,300 shares during the period. Alliancebernstein L.P. owned 0.16% of Molina Healthcare worth $26,615,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MOH. Wellington Management Group LLP lifted its holdings in Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after acquiring an additional 181,073 shares during the period. State Street Corp raised its stake in shares of Molina Healthcare by 0.5% during the 3rd quarter. State Street Corp now owns 2,614,311 shares of the company's stock worth $900,787,000 after purchasing an additional 13,001 shares during the period. Norges Bank purchased a new position in shares of Molina Healthcare in the 4th quarter worth about $134,675,000. Charles Schwab Investment Management Inc. grew its position in Molina Healthcare by 2.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company's stock valued at $116,443,000 after buying an additional 10,002 shares during the period. Finally, Los Angeles Capital Management LLC increased its holdings in Molina Healthcare by 166.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock worth $57,195,000 after buying an additional 122,674 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.

Remove Ads

Molina Healthcare Price Performance

Molina Healthcare stock traded up $2.62 during midday trading on Friday, reaching $345.30. 661,970 shares of the stock were exchanged, compared to its average volume of 653,643. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $378.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The firm has a market cap of $18.89 billion, a PE ratio of 16.90, a PEG ratio of 1.06 and a beta of 0.70. The company's fifty day moving average is $310.39 and its 200-day moving average is $308.18.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, sell-side analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Insider Buying and Selling at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on MOH shares. Truist Financial increased their target price on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research report on Friday. Stephens reissued an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a report on Thursday, February 6th. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $295.00 to $372.00 in a research report on Wednesday, March 5th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Finally, UBS Group decreased their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Seven investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $355.75.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.